FPB
First PREMIER Bank’s SAB Biotherapeutics SABS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33K | Hold |
18,986
| – | – | 0.01% | 249 |
|
|
2025
Q1 | $26K | Hold |
18,986
| – | – | 0.01% | 260 |
|
|
2024
Q4 | $72K | Sell |
18,986
-400
| -2% | -$1.52K | 0.02% | 208 |
|
|
2024
Q3 | $52K | Hold |
19,386
| – | – | 0.01% | 231 |
|
|
2024
Q2 | $60K | Buy |
+19,386
| New | +$60K | 0.02% | 201 |
|
|
2024
Q1 | – | Sell |
-807,535
| Closed | -$555K | – | 509 |
|
|
2023
Q4 | $555K | Hold |
807,535
| – | – | 0.16% | 101 |
|
|
2023
Q3 | $509K | Hold |
807,535
| – | – | 0.16% | 100 |
|
|
2023
Q2 | $670K | Hold |
807,535
| – | – | 0.19% | 90 |
|
|
2023
Q1 | $355K | Hold |
807,535
| – | – | 0.1% | 116 |
|
|
2022
Q4 | $476K | Hold |
807,535
| – | – | 0.14% | 95 |
|
|
2022
Q3 | $566K | Buy |
807,535
+155,095
| +24% | +$109K | 0.18% | 90 |
|
|
2022
Q2 | $946K | Buy |
+652,440
| New | +$946K | 0.28% | 76 |
|
|
2022
Q1 | – | Sell |
-832,555
| Closed | -$6.5M | – | 383 |
|
|
2021
Q4 | $6.5M | Buy |
+832,555
| New | +$6.5M | 1.68% | 16 |
|